|
|
Volumn 134, Issue 9 I, 2001, Pages 795-
|
|
Inhaled insulin: A proof-of-concept study [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEMOGLOBIN A1C;
INSULIN;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEVICE;
DIABETES MELLITUS;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
FOLLOW UP;
GLUCOSE METABOLISM;
HUMAN;
HYPOGLYCEMIA;
INHALATION;
INSULIN TREATMENT;
LETTER;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 0035340871
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-134-9_part_1-200105010-00020 Document Type: Letter |
|
Times cited : (18)
|
|
References (3)
|
